Skandinaviska Enskilda Banken (SEB)
ACET icon

Skandinaviska Enskilda Banken (SEB)’s Adicet Bio ACET Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,640
Closed -$243K – 943
2023
Q1 		$243K Sell
2,640
-127
-5% -$15.9K ﹤0.01% 814
2022
Q4 		$396K Sell
2,767
-161
-5% -$40.2K ﹤0.01% 749
2022
Q3 		$666K Buy
+2,928
New +$743K 0.01% 727

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s ACET Position: Q2 2023 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Adicet Bio (ACET) in Q2 2023, closing a stake of 2,640 shares — an estimated $243K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in ACET in Q3 2022 and held it in 3 quarters. The position peaked at $666K in Q3 2022. 94 funds tracked by Wall St. Rank hold ACET as of Q2 2023.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Adicet Bio position as of Q2 2023 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 2,640 Adicet Bio shares in Q2 2023, an estimated $243K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Adicet Bio in Q3 2022 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Adicet Bio position peaked at $666K in Q3 2022.
  • 94 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2023.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2023, filed 7 Aug 2023.